Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 1;13(1):e2023063.
doi: 10.5826/dpc.1301a63.

Treatment of Diabetes in Bullous Pemphigoid Patients: Where Do We Stand?

Maria Inês Alexandre  1 , Pedro Miguel Garrido  2 , Paulo Filipe  2   3   4
Affiliations

Treatment of Diabetes in Bullous Pemphigoid Patients: Where Do We Stand?

Maria Inês Alexandre et al. Dermatol Pract Concept. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing Interests: None.

Figures

Figure 1
Figure 1
Proposed treatment algorithm for bullous pemphigoid patients with type 2 diabetes mellitus treated with corticosteroids. BP, bullous pemphigoid; DM, diabetes mellitus; DPP4i, dipeptidyl peptidase-4 inhibitor; eGFR, estimated glomerular filtration rate; GLP1a, glucagon-like peptide 1 receptor agonist; SGLT2i, sodium–glucose cotransporter 2 inhibitor.
See this image and copyright information in PMC

References

    1. Chai ZT, Tan C, MeiQi Liau M, et al. Diabetes mellitus and hyperglycemic complications in bullous pemphigoid. J Am Acad Dermatol. 2020 May;82(5):1234–1237. - PubMed
    1. Di Lernia V, Casanova DM, Goldust M, Ricci C. Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment. Dermatol Pract Concept. 2020 Jun 29;10(3):e2020050. - PMC - PubMed
    1. Garrido PM, Alexandre MI, Travassos AR, Filipe P. Dipeptidyl-peptidase IV inhibitor-associated bullous pemphigoid efficiently treated with omalizumab. Dermatol Ther. 2020 Nov;33(6):e14160. - PubMed
    1. Kridin K, Cohen AD. Dipeptidyl-peptidase IV inhibitor-associated bullous pemphigoid: A systematic review and meta-analysis. J Am Acad Dermatol. 2021 Aug;85(2):501–503. - PubMed
    1. Burruss CP, Jones JM, Burruss JB. Semaglutide-associated bullous pemphigoid. JAAD Case Rep. 2021 Aug 5;15:107–109. - PMC - PubMed

LinkOut - more resources